[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100487881":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":32,"locations":33,"responsibleParty":306,"collaborators":32,"id":308,"slug":309,"hasResults":310,"nctId":311,"briefTitle":312,"officialTitle":313,"acronym":32,"eligibilityCriteria":314,"healthyVolunteers":310,"sex":315,"minAge":316,"maxAge":317,"enrollmentInfo":318,"targetDuration":32,"studyType":321,"phases":322,"briefSummary":324,"conditions":325,"keywords":32,"overallStatus":65,"whyStopped":32,"lastUpdateSubmitDate":327,"lastUpdatePostDateStruct":328,"startDateStruct":331,"completionDateStruct":333,"leadSponsor":335,"locationsCount":336},{"fullName":5,"class":6},"Tasly Pharmaceutical Group Co., Ltd","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental group","EXPERIMENTAL","HuHuangLianzonggan capsule, 4 pills, take orally after meals, 2 times a day",[13],"Drug: HuHuangLianzonggan capsule",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo group","PLACEBO_COMPARATOR","HuHuangLianzonggan capsule placebo, 4 pills, take orally after meals, 2 times a day",[19],"Drug: HuHuangLianzonggan capsule placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","HuHuangLianzonggan capsule","HuHuangLianzonggan capsule, 4 pills(120 mg per pill), take orally after meals, 2 times a day for 12weeks",[9],[9],{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"HuHuangLianzonggan capsule placebo","HuHuangLianzonggan capsule placebo, 4 pills(120 mg per pill), take orally after meals, 2 times a day for 12weeks",[15],[15],null,[34,53,63,78,92,106,121,135,151,165,178,188,201,215,229,243,257,270,280,293],{"facility":35,"status":36,"city":37,"state":38,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Anhui Provincial Hospital","NOT_YET_RECRUITING","Hefei","Anhui","China","CN",{"type":42,"coordinates":43},"Point",[44,45],117.28083,31.86389,{"lat":45,"lon":44},[48],{"name":49,"role":50,"phone":51,"phoneExt":32,"email":52},"Yuanyuan Xu","CONTACT","0551-62283160","13855184991@163.com",{"facility":54,"status":36,"city":37,"state":38,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":55,"geoPoint":57,"contacts":58},"The Second Hospital of Anhui Medical University",{"type":42,"coordinates":56},[44,45],{"lat":45,"lon":44},[59],{"name":60,"role":50,"phone":61,"phoneExt":32,"email":62},"Guizhou Zou","0551-3869420","zouguizhou@126.com",{"facility":64,"status":65,"city":66,"state":67,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Peking University Third Hospital","RECRUITING","Beijing","Beijing Municipality",{"type":42,"coordinates":69},[70,71],116.39723,39.9075,{"lat":71,"lon":70},[74],{"name":75,"role":50,"phone":76,"phoneExt":32,"email":77},"Xiaoguang Li","010-82266699","caitlin901@163.com",{"facility":79,"status":36,"city":80,"state":81,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"The first affiliated hospital of Fujian medical university","Fuzhou","Fujian",{"type":42,"coordinates":83},[84,85],119.30611,26.06139,{"lat":85,"lon":84},[88],{"name":89,"role":50,"phone":90,"phoneExt":32,"email":91},"Yueyong Zhu","0591-87983333","ezhu066@sina.com",{"facility":93,"status":36,"city":94,"state":95,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Nanfang Hospital, Southern Medical University","Guangzhou","Guangdong",{"type":42,"coordinates":97},[98,99],113.25,23.11667,{"lat":99,"lon":98},[102],{"name":103,"role":50,"phone":104,"phoneExt":32,"email":105},"Side Liu","020-61641888","liuside@163.com",{"facility":107,"status":65,"city":108,"state":95,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"The Third People's Hospital of Shenzhen","Shenzhen",{"type":42,"coordinates":110},[111,112],114.0683,22.54554,{"lat":112,"lon":111},[115,119],{"name":116,"role":50,"phone":117,"phoneExt":32,"email":118},"Guojun Li","0755-61222333","13615880689@163.com",{"name":120,"role":50,"phone":117,"phoneExt":32,"email":32},"Xin Deng",{"facility":122,"status":65,"city":123,"state":124,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":125,"geoPoint":129,"contacts":130},"The First Affiliated Hospital of Henan University of Science and Technology","Luoyang","Henan",{"type":42,"coordinates":126},[127,128],112.43684,34.67345,{"lat":128,"lon":127},[131],{"name":132,"role":50,"phone":133,"phoneExt":32,"email":134},"Yingjian Zhang","0379-64830604","13783131268@163.com",{"facility":136,"status":65,"city":137,"state":138,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":139,"geoPoint":143,"contacts":144},"Union Hospital Tongji Medical College Huazhong University of Science and Technology","Wuhan","Hubei",{"type":42,"coordinates":140},[141,142],114.26667,30.58333,{"lat":142,"lon":141},[145,149],{"name":146,"role":50,"phone":147,"phoneExt":32,"email":148},"Ling Yang","027-85726114","13971178791@163.com",{"name":150,"role":50,"phone":147,"phoneExt":32,"email":32},"Rong Lin",{"facility":152,"status":65,"city":153,"state":154,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":155,"geoPoint":159,"contacts":160},"The First People's Hospital of Lianyungang","Lianyungang","Jiangsu",{"type":42,"coordinates":156},[157,158],119.21556,34.59845,{"lat":158,"lon":157},[161],{"name":162,"role":50,"phone":163,"phoneExt":32,"email":164},"Wenhai Zhao","0518-85452253","Zhaowenhai56@163.com",{"facility":166,"status":36,"city":167,"state":154,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":168,"geoPoint":172,"contacts":173},"The Affiliated Hospital of Nanjing University medical school，Nanjing Drum Tower Hospital","Nanjing",{"type":42,"coordinates":169},[170,171],118.77778,32.06167,{"lat":171,"lon":170},[174],{"name":175,"role":50,"phone":176,"phoneExt":32,"email":177},"Jie Li","025-83106666","lijier@sina.com",{"facility":179,"status":65,"city":167,"state":154,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":180,"geoPoint":182,"contacts":183},"The Second Hospital of Nanjing",{"type":42,"coordinates":181},[170,171],{"lat":171,"lon":170},[184],{"name":185,"role":50,"phone":186,"phoneExt":32,"email":187},"Yanhong Feng","025-58006129","aaa_mike@sina.com",{"facility":189,"status":65,"city":190,"state":154,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":191,"geoPoint":195,"contacts":196},"The Affiliated Hospital of Xuzhou Medical University","Xuzhou",{"type":42,"coordinates":192},[193,194],117.28386,34.20442,{"lat":194,"lon":193},[197],{"name":198,"role":50,"phone":199,"phoneExt":32,"email":200},"Xuebing Yan","0516-85609999","Yxbxuzhou@126.com",{"facility":202,"status":36,"city":203,"state":204,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":205,"geoPoint":209,"contacts":210},"General Hospital of Ningxia Medical University","Yinchuan","Ningxia",{"type":42,"coordinates":206},[207,208],106.27306,38.46806,{"lat":208,"lon":207},[211],{"name":212,"role":50,"phone":213,"phoneExt":32,"email":214},"Huiping Sheng","0951-6744457","shenghuipingnx@163.com",{"facility":216,"status":65,"city":217,"state":218,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":219,"geoPoint":223,"contacts":224},"Sichuan Provincial People's Hospital","Chengdu","Sichuan",{"type":42,"coordinates":220},[221,222],104.06667,30.66667,{"lat":222,"lon":221},[225],{"name":226,"role":50,"phone":227,"phoneExt":32,"email":228},"Liangping Li","028-87393999","18981838872@163.com",{"facility":230,"status":65,"city":231,"state":232,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":233,"geoPoint":237,"contacts":238},"Tianjin Second People's Hospital","Tianjin","Tianjin Municipality",{"type":42,"coordinates":234},[235,236],117.17667,39.14222,{"lat":236,"lon":235},[239],{"name":240,"role":50,"phone":241,"phoneExt":32,"email":242},"Liang Xu","022-27468102","xuyangliang2004@sina.com",{"facility":244,"status":65,"city":245,"state":246,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":247,"geoPoint":251,"contacts":252},"The Affiliated Hospital of Hangzhou Normal University","Hangzhou","Zhejiang",{"type":42,"coordinates":248},[249,250],120.16142,30.29365,{"lat":250,"lon":249},[253],{"name":254,"role":50,"phone":255,"phoneExt":32,"email":256},"Junping Shi","0571-88015050","13957121199@vip.126.com",{"facility":258,"status":65,"city":259,"state":246,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":260,"geoPoint":264,"contacts":265},"Ningbo Huamei Hospital, University of Chinese Academy of Sciences","Ningbo",{"type":42,"coordinates":261},[262,263],121.54945,29.87819,{"lat":263,"lon":262},[266],{"name":267,"role":50,"phone":268,"phoneExt":32,"email":269},"Hongshan Li","0574-83870999","lihongshan_1982@126.com",{"facility":271,"status":65,"city":259,"state":246,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":272,"geoPoint":274,"contacts":275},"Ningbo Medical Center Lihuili Hospital",{"type":42,"coordinates":273},[262,263],{"lat":263,"lon":262},[276],{"name":277,"role":50,"phone":278,"phoneExt":32,"email":279},"Yufei Song","0574-87018701","517582445@qq.com",{"facility":281,"status":65,"city":282,"state":246,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":283,"geoPoint":287,"contacts":288},"Taizhou Municipal Hospital","Taizhou",{"type":42,"coordinates":284},[285,286],121.43312,28.66266,{"lat":286,"lon":285},[289],{"name":290,"role":50,"phone":291,"phoneExt":32,"email":292},"Qian Jin","0576-88858000","13957685075@163.com",{"facility":294,"status":65,"city":295,"state":246,"zip":32,"country":39,"countryCode":40,"cosmosGeoPoint":296,"geoPoint":300,"contacts":301},"Rui'an People's Hospital","Wenzhou",{"type":42,"coordinates":297},[298,299],120.66682,27.99942,{"lat":299,"lon":298},[302],{"name":303,"role":50,"phone":304,"phoneExt":32,"email":305},"Liang Hong","0577-58815881","rahoshongliang@163.com",{"type":307,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR","100487881","phase-2-huhuanglianzonggan-capsule-in-subjects-with-nonalcoholic-steatohepatitis-a-phase-2-trialhhl-hepar-100487881",false,"NCT05632861","HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)","Efficacy and Safety of HuHuangLianzonggan Capsule in Subjects With Nonalcoholic steatoHEPAtitis: a Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 tRial(HHL-HEPAR)","Inclusion Criteria:\n\n1. Males and females between 18-75 years of age inclusive(including boundary values).\n2. Must have had a liver biopsy proven NASH within 6 months or in screening test. The following two requirements must be met at the same time: ① a non-alcoholic fatty liver disease (NAFLD) activity score (NAS) of ≥ 4 with at least a score of 1 in each of the following NAS components: Steatosis≥1, Lobular inflammation≥1, Ballooning degeneration≥1;② fibrosis stage 1 to 3.\n3. Must have confirmation of ≥ 8% liver fat content on magnetic resonance imaging- proton density fat fraction (MRI-PDFF) at screening.\n4. No alcohol consumption or history of excessive alcohol consumption: less than 210 g of ethanol per week for men and 140 g for women in the past 12 months.\n5. Patients who are taking chronic drugs(including but not limited to antihypertensive drugs, antiatherogenic drugs, oral hypoglycemic drugs, insulin) need to have a steady dose for at least 3 months before liver biopsy.\n6. Weight was stable(the change is no more than 5%) during the 6 months prior to Screening.\n7. No attempt to change lifestyle (diet and\u002For exercise) during the 3 months prior to Screening.\n8. Ability to understand the requirements of the study and willingness to provide written informed consent.\n9. Have no pregnancy program and take effective contraceptive measures voluntarily.\n10. Abide by the experimental protocol and cooperate with the data collection according to the researcher's judgment.\n\nExclusion Criteria:\n\n1. Treatment with drugs that may cause non-alcoholic fatty liver disease (NAFLD) administered for at least 2 weeks within 12 months prior to qualifying liver biopsy (e.g. valproic acid, tamoxifen, methotrexate, amiodarone, oral corticosteroids, \\>5 mg\u002Fday of prednisone equivalent \\[one short (\\\u003C2 weeks) course of oral corticosteroids, more than 3 months before the liver biopsy is allowed\\], or oestrogens \\[at doses greater than those used for contraception or hormone replacement\\]).\n2. Documented causes of fatty liver disease other than NASH including, but not restricted to: HCV-associated fatty liver (genotype 3), hepatolenticular degeneration, autoimmune hepatitis, total parenteral nutrition, abetalipoproteinemia, lipoatrophy , Coeliac disease, Primary sclerosing cholangitis, Alpha-1-antitrypsin deficiency, Drug-induced liver disease.\n3. Model for End-stage Liver Disease (MELD) score \\>12.\n4. Histologically documented liver cirrhosis (fibrosis stage F4), history or current diagnosis of hepatocellular carcinoma HCC.\n5. History of or planned liver transplant.\n6. Viral hepatitis：Positive hepatitis A antibody，Positive hepatitis D antibody，Positive hepatitis E antibody，Positive hepatitis B surface antigen (HBsAg) ，Positive hepatitis C antibody.\n7. Abnormal liver function as defined by Screening central laboratory evaluation of any of the following: ALT or AST \\>5 × ULN; Alkaline phosphatase (ALP) \\>2 × ULN; albumin below the lower limit of the normal range; total bilirubin level \\>1.5 × ULN (patients with a documented history of Gilbert's syndrome can be enrolled if the direct bilirubin is within normal reference range).\n8. In patients who are not anticoagulated, INR ≥ 1.3 times ULN or other evidence of impaired coagulation.\n9. Renal impairment measured as estimated Glomerular Filtration Rate (eGFR) value \\\u003C30 mL\u002Fmin\u002F1.73 m2.\n10. Patient currently receiving any approved treatment for NASH.\n11. HbA1c ≥9% or fasting blood-glucose\\>13.9 mmol\u002FL at Screening.\n12. Diabetes mellitus other than type 2 (e.g. type 1, diabetes caused by drugs or chemicals, and immune-mediated diabetes).\n13. Those who are underweight, of normal weight, or severely obese, i.e BMI\\\u003C23 kg\u002Fm2 or BMI≥40 kg\u002Fm2.\n14. Bariatric surgery or tumor surgery are not allowed within 5 years of the qualifying liver biopsy.\n15. Uncontrolled hypertension (values ≥160\u002F100 mm Hg) or hypotension（values \\\u003C80\u002F50 mmHg）.\n16. Acute vascular events including ACS, stroke, peripheral vascular disease worsened, or any vascular\u002Fcardiac surgery within the 6 months prior to Screening.\n17. Concomitant mental illness and poor condition control, which affects the signing of informed consent or presentation of adverse events.\n18. Do not have a liver biopsy within the 6 months prior to Screening and refuse to take liver biopsy at Screening.\n19. Allergic constitution, or allergic to the test drug or its ingredients.\n20. Women who are pregnant or lactating.\n21. Participate in clinical trials of other drugs within 3 months before screening.\n22. The researchers did not consider it appropriate to participate in this study.","ALL","18 Years","75 Years",{"count":319,"type":320},76,"ESTIMATED","INTERVENTIONAL",[323],"PHASE2","This study will evaluate the efficacy and safety and the best effective dose of HuHuangLianzonggan capsule in subjects with nonalcoholic steatohepatitis.",[326],"NASH","2024-08-28",{"date":329,"type":330},"2024-08-29","ACTUAL",{"date":332,"type":330},"2023-02-21",{"date":334,"type":320},"2024-12-31",{"name":5,"class":6},20]